The global campaign against drug counterfeiting is on
for the last several years and in particular growing
fast according to the western industry circles including
the WHO, under whose aegis a special task force known as
IMPACT as been set up. Scare stories are spread that the
global counterfeiting industry will reach a level of 70
Billion Dollars by 2015, unless the anti-counterfeiting
steps are taken seriously by every major country and its
regulatory mechanism and standards are brought on par
with the western world.
India is an emerging big player in the pharmaceutical
world and is going to be a global hub for generic
product manufacture and supply base to the highly
regulated countries like the USA, Japan, EU and
Australia. More and more Indian companies big and small
have set up manufacturing facilities on par with the
western standards. Thus India is a big hardware to the
western world’s soft ware of knowledge.
India’s pharmaceutical market size is forecast,
according to Mackinsey’s projection, to grow at a CAGR
of 11+ % in the next few years to $ 20 billion by 2015
from $ 6.00 billion in 2005.
At the same time the largest pharmaceutical market by
size that is the US will move from $248 billion in 2005
to $ 444 billion by the same Mackinsey report. More and
more products from the west are going to be out sourced
for manufacture from Indian facilities. This is a sequel
to the rapidly growing cost of Health care in the
western world and their Governments policy to encourage
prescription of generic products in an effort to control
the Health Care costs for their Citizens.
Since Indian companies though world class are able to
manufacture products at fraction of the cost prevailing
in the western factories, out sourcing of pharmaceutical
manufacture to countries like India and China are going
to be the increasing trend.
As counterfeiting problems are on the rise and its slow
spread into the supply chain in the western world
proving to be a great menace, Indian companies will be
adopting forensic anti-counterfeiting technologies such
as RFID, DMS (digital mass serialization), DME ( digital
mass encryption) and many more versions of Trace and
Track technology such as 2 D bar code on every pack and
even on the dosage form such as a Tablet or a capsule
are going to be the norm.
For full text of this article contact the publisher on